SANTA CLARA, Calif.,
April 18, 2011 /PRNewswire/ --
NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic
technology provider, announced today that Vincent Renz, President and Chief Executive
Officer, will participate in the Benchmark Company, LLC One-on-One
Investor Conference on Thursday, May 12,
2011 at The Pfister Hotel, 424 East Wisconsin Ave.,
Milwaukee, Wis. The conference
will include a number of one-on-one meetings arranged by Benchmark
with investors. Investors planning to attend the conference should
contact their Benchmark representative to arrange a meeting.
About The Benchmark Company, LLC
Headquartered in New York City,
The Benchmark Company, LLC is an institutional brokerage firm with
a strong sales/trading presence in addition to its rapidly
expanding research and investment banking arms. In just nine years,
Benchmark has established offices in 12 cities throughout the
country.
About NewCardio, Inc.
NewCardio is a cardiac diagnostic and services company
developing and marketing proprietary software platform technologies
to provide higher accuracy to, and increase the value of, the
standard 12L ECG. NewCardio's 3-D ECG software platform reduces the
time and expense involved in assessing cardiac status while
increasing the ability to diagnose clinically significant
conditions which were previously difficult to detect. NewCardio's
software products and services significantly improve the diagnosis
and monitoring of cardiovascular disease, as well as cardiac safety
assessment of drugs under development. For more information, visit
www.newcardio.com.
To join our email distribution please click this link:
http://www.b2i.us/irpass.asp?BzID=1645&to=ea&s=0
Investor Contact:
Hayden IR
Jeff Stanlis, Partner
(602) 476-1821
jeff@haydenir.com
SOURCE NewCardio, Inc.
